Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure.
about
The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update.Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally).Pharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders.Metoprolol oxidation polymorphism in Brazilian elderly cardiac patients.Simultaneous Determination and Comparative Pharmacokinetics of Fuzi Water-Soluble Alkaloids between Normal and Acute Heart Failure Rats by Ultra Performance Liquid Chromatography Method.
P2860
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Fluvoxamine pharmacokinetics i ...... ts with chronic heart failure.
@en
Fluvoxamine pharmacokinetics i ...... ts with chronic heart failure.
@nl
type
label
Fluvoxamine pharmacokinetics i ...... ts with chronic heart failure.
@en
Fluvoxamine pharmacokinetics i ...... ts with chronic heart failure.
@nl
prefLabel
Fluvoxamine pharmacokinetics i ...... ts with chronic heart failure.
@en
Fluvoxamine pharmacokinetics i ...... ts with chronic heart failure.
@nl
P2093
P2860
P1476
Fluvoxamine pharmacokinetics i ...... nts with chronic heart failure
@en
P2093
Laura Andrighetto
Maura Floreani
Pietro Palatini
Rocco Orlando
P2860
P304
P356
10.1111/J.1365-2125.2009.03587.X
P407
P577
2010-03-01T00:00:00Z